UMass Chan Medical School Initiates Clinical Trial for Psychedelic Medication in Adjustment Disorder Patients with Serious Medical Conditions

UMass Chan Medical School has launched a clinical trial to evaluate the effectiveness of an investigational psychedelic medication, 4-OH-DiPT, in treating adjustment disorder among individuals diagnosed with serious medical conditions such as cancer, ALS, multiple sclerosis, Parkinson's disease, or idiopathic pulmonary fibrosis. This lab-made chemical acts similarly to psilocybin. The study, led by Dr. Anthony Rothschild, aims to address the lack of FDA-approved treatments for adjustment disorder and builds on existing research into psychedelic medications for mental health.